Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 880 of 5804
-
Surgery showdown: can debulking beat drugs for pancreatic cancer?
Disease control Recruiting nowPancreatic neuroendocrine tumours (pan-NETs) are neoplasms arising from the endocrine cells of the pancreas. Although pan-NET are quite rare, the incidence is on the rise and together with other abdominal neuroendocrine tumours an approximate incidence in Sweden would be 850 pati…
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug aims to stop kidney transplant rejection without antibodies
Disease control Recruiting nowIn this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition called microvascular inflammation (MVI). MVI is a type of injury to small blood vessels in the transplanted kidney and may be…
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a simple pressure change keep pneumonia patients off ventilators?
Disease control Recruiting nowNoninvasive ventilation is commonly employed in patients with pneumonia or acute respiratory distress syndrome (ARDS) and has been shown to reduce the need for intubation and invasive mechanical ventilation. However, the rate of noninvasive ventilation failure remains substantial…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for rare adrenal cancer: drug trial launches
Disease control Recruiting nowThis is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New trial aims to solve the mystery of cancers with unknown origins
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to improve diagnosis and treatment strategies for patients with Cancer of Unknown Primary (CUP) by using advanced molecular profiling to identify the likely tumor origin and guide therapy. The main questions it aims to answer are: Can comprehe…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
New hope for high-risk prostate cancer: drug duo after surgery may stop recurrence
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether adjuvant darolutamide plus androgen-deprivation therapy (ADT) can reduce post-operative recurrence and improve disease control in high-risk prostate cancer patients-defined by the Briganti 2019 nomogram-who have undergone rad…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New surgical technique aims to reduce cancer spread in cervical cancer patients
Disease control Not yet recruitingThis study is a multicenter, open-label, non-inferiority, randomized controlled, investigator-initiated clinical trial comparing the efficacy and safety of open radical hysterectomy versus minimally invasive radical hysterectomy using an endoscopic stapler as surgical treatments …
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Infusion or bolus? study tests best steroid delivery for septic shock
Disease control CompletedSeptic shock is a life-threatening condition in which infection causes dangerously low blood pressure and organ dysfunction despite fluid resuscitation and vasopressor treatment. Hydrocortisone is commonly used in patients with septic shock who continue to require vasopressors. H…
Phase: PHASE4 • Sponsor: Benha University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aimed at saving lives after stem cell transplants
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of Iptacopan as a second-line treatment for high-risk hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA). Iptacopan is a selective oral small-molecule complement factor B in…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Zapping kidney nerves could tame stubborn high blood pressure
Disease control Recruiting nowThe RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medications at a therapeutic dose. The novelty of the RPDTM system relates to its placem…
Phase: NA • Sponsor: Verve Medical, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Ancient acupoint plaster could cut opioid use in cancer pain
Symptom relief Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of acupoint application with Gutong Plaster for treating moderate to severe cancer pain in patients aged ≥18 years with moderate to severe cancer pain (NRS 4-8), ECOG 0-3, life expectancy ≥3 months. The main questions i…
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could Pre-Surgery drugs shrink thyroid tumors and improve outcomes?
Disease control Recruiting nowThis multicenter observational study aims to evaluate the safety and efficacy of neoadjuvant therapy in patients with locally advanced thyroid cancer, focusing on imaging, biochemical, and pathological responses, as well as short-term surgical outcomes and long-term prognosis.
Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill could ease severe psoriasis in just 12 weeks
Disease control Recruiting nowThe purpose of this study is to compare the efficacy and safety of ICP-332 to placebo in participants with moderate-to-severe plaque psoriasis.
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New gene therapy targets tough cancers in early trial
Disease control Recruiting nowThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug could help regrow hair in severe alopecia
Disease control Recruiting nowThe main aim of the study is to evaluate the effect of LAD603 in adult participants with severe to very severe alopecia areata (AA). The study will also evaluate the safety, pharmacokinetics (PK), immunogenicity and pharmacodynamic (PD) biomarkers of LAD603.
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Ear acupressure could replace standard drugs for chemo nausea
Symptom relief Recruiting nowThis study aims to evaluate whether the preventive and suppressive effects of auricular point stimulation combined with dexamethasone on nausea and vomiting induced by the docetaxel plus cyclophosphamide regimen are non-inferior to the standard antiemetic regimen. Additionally, i…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
AI learns to see inside your throat: new tool could catch disease early
Diagnosis Recruiting nowAn artificial intelligence-assisted system is trained and validated by collecting nasopharyngolaryngoscopy images from patients.
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New drug hopes to halt liver damage in MASH patients
Disease control Recruiting nowThis study will evaluate the safety and tolerability of Efimosfermin Alfa for participants with known or suspected MASH with fibrosis consistent with stage F2 or F3.
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a blood spin boost baby chances? new trial tests PRP in IUI
Disease control Not yet recruitingHypotheses: We hypothesize that infertility patients undergoing IUI who receive female autologous platelet-rich plasma (PRP) co-incubation with husband's sperm would have higher clinical pregnancy rate. Aims: * To determine if the use of female autologous platelet-rich plasma …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a simple supplement save feverish kids in poor countries?
Disease control Recruiting nowIn low and middle-income countries, children admitted to hospital are not similarly ill, and do not all have a comparable prognosis. In fact, understanding at first encounter their risk of developing adverse outcomes (including mortality) could allow a more focused management and…
Phase: NA • Sponsor: Barcelona Institute for Global Health • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC